2024 Warren Alpert Prize Honors Four Pioneers in CAR T-Cell Therapy

Lab-Altered Immune Cells Offer Lifeline for Patients with Blood Cancers

At a glance:

  • The four scientists developed genetically engineered immune cells to combat several blood cancers.
  • CAR T-cell therapy has redefined the treatment of blood cancers, saving the lives of tens of thousands of people.
  • The therapy works by modifying patients’ own T cells, improving their ability to fight tumors with punch and precision.

The 2024 Warren Alpert Foundation Prize has been awarded to four scientists whose transformational discoveries led to the creation of chimeric antigen receptor (CAR) T cells, a treatment that modifies patients’ immune cells and optimizes their ability to eliminate cancer cells.

Login Or Register To Read Full Story